Health News Stories

Excerpts of Key Health News Stories in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

The sugar industry funded animal research in the 1960s that looked into the effects of sugar consumption on cardiovascular health - and then buried the data when it suggested that sugar could be harmful, according to newly released historical documents. Stanton Glantz, a professor of medicine at U.C.S.F. and an author of the new report, said that even though the newly discovered documents are 50 years old, they are important because they point to a decades-long strategy to downplay the potential health effects of sugar consumption. “This is continuing to build the case that the sugar industry has a long history of manipulating science,” Dr. Glantz said. The documents described in the new report are part of a cache of internal sugar industry communications that Cristin E. Kearns, an assistant professor at the U.C.S.F. School of Dentistry, discovered in recent years. Last year, an article in The New York Times highlighted some of the previous documents that Dr. Kearns had uncovered, which showed that the sugar industry launched a campaign in the 1960s to counter “negative attitudes toward sugar” in part by funding sugar research that could produce favorable results. The campaign was orchestrated by John Hickson, a top executive at the sugar association who later joined the tobacco industry. Mr. Hickson secretly paid two influential Harvard scientists to publish a major review paper in 1967 that minimized the link between sugar and heart health and shifted blame to saturated fat.

Note: Read more about the sugar industry conspiracy. For more along these lines, see concise summaries of deeply revealing news articles on corruption in the food system and in the scientific community.

More than four decades ago, a study in rats funded by the sugar industry found evidence linking the sweetener to heart disease and bladder cancer. The results of that study were never made public. Instead, the sugar industry pulled the plug on the study and buried the evidence, said senior researcher Stanton Glantz, a professor of medicine and director of the University of California, San Francisco (UCSF) Center for Tobacco Control Research and Education. Glantz likened this to suppressed Big Tobacco internal research linking smoking with heart disease and cancer. "This was an experiment that produced evidence that contradicted the scientific position of the sugar industry," Glantz said. "It certainly would have contributed to increasing our understanding of the cardiovascular risk associated with eating a lot of sugar, and they didn't want that." Researchers at the University of Birmingham in England conducted Project 259 between 1967 and 1971, comparing how lab rats fared when fed table sugar versus starch. The scientists specifically looked at how gut bacteria processed the two different forms of carbohydrate. Early results in August 1970 indicated that rats fed a high-sugar diet experienced an increase in blood levels of triglycerides, a type of fat that contributes to cholesterol. Rats fed loads of sugar also appeared to have elevated levels of beta-glucuronidase, an enzyme previously associated with bladder cancer in humans, the researchers said.

Note: Read more about the sugar industry conspiracy. For more along these lines, see concise summaries of deeply revealing news articles on corruption in the food system and in the scientific community.

People are firmly in charge of much of their own risk of cancer. The team at Harvard Medical School calculated that 20 to 40 percent of cancer cases, and half of cancer deaths, could be prevented if people quit smoking, avoided heavy drinking, kept a healthy weight, and got just a half hour a day of moderate exercise. They used data from long-term studies of about 140,000 health professionals who update researchers on their health every two years for the analysis, published in the Journal of the American Medical Association’s JAMA Oncology. These figures increased to 40 percent to 70 percent when assessed with regard to the broader U.S. population of whites, which has a much worse lifestyle pattern than our cohorts,” Dr. Mingyang Song and Dr. Edward Giovannucci of Harvard Medical School wrote. "The findings of the current study provide strong support for the argument that a large proportion of cancers are due to environmental factors and can be prevented by lifestyle modification." By "environmental," they mean non-genetic causes. To a scientist, environment includes diet, exercise and other factors. “Cancer is preventable,” Dr. Graham Colditz and Dr. Siobhan Sutcliffe of Washington University School of Medicine ... agreed in a commentary. “In fact, most cancer is preventable - with estimates as high as 80 percent to 90 percent for smoking-related cancers ... and as high as 60 percent for other common, lifestyle-related cancers.”

Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

A Minnesota-based health system has fired about 50 employees who refused to get a flu shot. Essentia Health announced last month that employees would be required to get vaccinated for influenza unless they received a religious or medical exemption. The company said it wanted to help keep patients from getting sick at its 15 hospitals and 75 clinics in Minnesota, Idaho, North Dakota and Wisconsin. Essentia says 99 percent of the company's 13,900 eligible employees had gotten the shot, received an exemption or were getting an exemption by the Monday deadline. The United Steelworkers filed an injunction to try to delay the policy, but a federal judge denied the request. Minnesota Public Radio reports at least two other unions are filing grievances on behalf of workers who lost their jobs.

Note: For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.

The 2,190-mile long Appalachian Trail is daunting even to those who have no trouble walking. That hasn't stopped Stacey Kozel. Her paralyzed body hasn't stopped her, either. The 41-year-old ... was always active until lupus stole her muscles and strength. Since her diagnosis at 19, she ... had always managed to get back on her feet - until a flare-up in March 2014. "I walked into a hospital, came out in a wheelchair," recalled Stacey Kozel. Although Kozel was able to walk stiffly with an old pair of braces, they wouldn't help her walk comfortably enough to embrace the outdoors. The chance finally came when she came across the Ottobock C-Brace. The brace functions essentially as the muscles and bones of a leg. The price tag for the technology was steep: $75,000 each. Kozel's doctors and therapists knew that getting these braces covered by insurance would be an uphill climb. When her claim was finally approved after 12 months, she was "in shock." Three days after Kozel got her braces, Joey Pollak, Kozel's orthopedist, got a call saying Kozel was in a 5K race. "To say Stacey is an overachiever is an understatement," said Pollak. What Pollak did not know was an idea forming in Kozel's head. She wanted to show insurance companies how useful the braces can be for those who have lost their mobility. She set her mind on the Appalachian Trail, just two months after she received her braces. Now, with support from her orthopedist, her mother and strangers along the way, she is slowly approaching her destination.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

If you had asked me 20 years ago where I would be, I never would have imagined I would be a physician working at UCLA Health, one of the best medical centers in the country. For over 25 years, my physical disability threatened to define who I was and what others thought I could become. I contracted meningococcal disease at 8 years of age. The infection overwhelmed my body's defenses, and I became a triple amputee. The disease left me with just enough to survive and carry on: two full fingers of the left hand, the thumb and ring finger. The first few years were physically and emotionally grueling; I was in and out of the hospital for surgical procedures to make my lower limbs fit better into prosthetic legs. I couldn't walk for nearly three years. I grew so quickly, my prosthetic legs could not keep up. My father would give me piggyback rides from the car to our house. My mother, who became blind as a teen, learned how to help me dress and put on my prosthetic legs every morning for school. My younger brother, Tarring, would help bring things to me since my mobility was limited. And my older sister, Nellie, was and is my inspiration and role model. I have been extremely lucky to have a strong and resilient family. I was lucky to be in a place where I had great medical care and where I had a community of friends and schools that supported my recovery and believed in my ability to succeed despite my disability. But luck is only part of my success; it takes courage, determination, honesty and integrity to pursue your dreams.

Note: Dr. Kellie Lim, author of this article received her medical training from the David Geffen School of Medicine at the University of California, Los Angeles. After getting her medical degree, she completed her residency in pediatrics before pursuing fellowship training in allergy & immunology and pharmacology. Today, she works as an allergist-immunologist at UCLA Health. Explore a treasure trove of summaries of news articles on incredibly inspiring disabled persons.

In July, the Food and Drug Administration took the important step of approving two final-phase clinical trials to determine whether a party drug that has long been on the Drug Enforcement Administration’s Schedule I list of banned substances could be used to treat a psychiatric condition that afflicts millions. The drug is MDMA, a psychedelic commonly known as Ecstasy. The trials aim to determine whether the drug is, as earlier trials have suggested, a safe and effective treatment for post-traumatic stress disorder. The F.D.A. approval is a beacon of hope for the roughly eight million Americans believed to suffer from PTSD, a group that includes victims of abuse, refugees and combat veterans. The shortcomings in the way we have typically treated PTSD mean that many are condemned to suffer from the condition for years, even decades, with little relief. Less than 20 percent of patients are estimated to get effective treatment through prescription psychiatric drugs ... which, along with psychotherapy, have been the global standard of mental health care since the 1990s. This could change with the F.D.A.’s decision, which has given MDMA-assisted psychotherapy for the treatment of PTSD the status of a potential “breakthrough therapy.” This designation permits the fast-tracking of trials in hopes of proving the drug, which has psychedelic and stimulant effects, to be safe and capable of doing what no other drug on the market can.

Note: Read more about how MDMA has been found to be highly effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.

Overdoses are now the leading cause of death of Americans under the age of 50. According to preliminary data compiled by The New York Times, deaths last year likely topped 59,000 - 19 percent more than the year before. In Ohio, they were up even more. On May 26, Cleveland Police Sgt. Timothy Maffo-Judd's body camera was running as he approached a man slumped in his car. It turned out that the man was minutes from a fatal drug overdose. Three applications of Narcan - the anti-overdose drug - and the victim finally started coming around. Maffo-Judd says it's become a grim routine, and he's even encountered the same person twice. "That's pretty common," he says. In Ohio, at least 4,100 people died from unintentional drug overdoses last year - a 36 percent increase from 2015, when the state led the nation in overdose deaths. Kentucky, West Virginia and New Hampshire have also experienced shocking increases, along with the East Coast. Most of it is tied to heroin or prescription painkillers, often laced with a powerful synthetic opioid known as fentanyl. In Ohio alone, nearly four billion opioid pills were prescribed across Ohio between 2011 and 2015. Ohio is now suing five big drug companies that manufacture prescription painkillers, charging that they knowingly minimize the risks of addiction. As Attorney General Mike Dewine put it: "They knew they were wrong but they did it anyway and they continue to do it."

Note: This excellent article has lots more on the intense level of corruption found in this opioid crisis. For more, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry.

Two days after agreeing to pay states nearly $20 million for falsely marketing OxyContin, the drug's maker, Perdue Pharma, and three current and former executives plead guilty to federal charges. The Stamford, Conn.-based maker of the powerful painkiller, and three of its current and former executives, pleaded guilty Thursday to misleading the public about OxyContin's risk of addiction. Purdue Pharma L.P., its president, top lawyer and former chief medical officer will pay $634.5 million in fines for claiming the drug was less addictive and less subject to abuse than other pain medications, U.S. Attorney John Brownlee said. The plea agreement comes after the company agreed to pay $19.5 million to 26 states and the District of Columbia to settle complaints that it encouraged physicians to overprescribe OxyContin. Even though the company was warned by health professionals, the media and members of its own sales force, "Perdue continued to push a fraudulent marketing campaign that promoted OxyContin as less addictive, less subject to abuse and less likely to cause withdrawal when they knew in fact that that was not true," Brownlee told CBS News correspondent Barry Bagnato. "Doctors are often approached right in their offices by pharmaceutical company sales reps dispensing information about one medication or another," said CBS News medical correspondent Dr. Jon LaPook. "This case is a reminder to doctors not to believe everything they hear."

Note: The family which owns Purdue, maker of OxyContin, is among the 20 richest families in the U.S., thanks largely to sales of Oxycontin, which has resulted in thousands of overdose deaths, according to this article in Forbes. For more, see this revealing article. Then see concise summaries of deeply revealing news articles on pharmaceutical industry corruption and health.

Regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken. The digital pill combines two existing products: the former blockbuster psychiatric medication Abilify - long used to treat schizophrenia and bipolar disorder - with a sensor tracking system first approved in 2012. Experts say the technology could be a useful tool, but it will also change how doctors relate to their patients as they’re able to see whether they are following instructions. The pill has not yet been shown to actually improve patients’ medication compliance, a feature insurers are likely to insist on before paying for the pill. Additionally, patients must be willing to allow their doctors and caregivers to access the digital information. The technology carries risks for patient privacy, too, if there are breaches of medical data or unauthorized use as a surveillance tool, said James Giordano, a professor of neurology at Georgetown University Medical Center. “Could this type of device be used for real-time surveillance? The answer is of course it could,” said Giordano. The new pill, Abilify MyCite, is embedded with a digital sensor that is activated by stomach fluids, sending a signal to a patch worn by the patient and notifying a digital smartphone app that the medication has been taken.

Note: In 2010, it was quietly reported that Novartis AG would be seeking regulatory approval for such "chip-in-a-pill technology". For more along these lines, see concise summaries of deeply revealing news articles on microchip implants and the disappearance of privacy.

More than 6,000 cases of mumps were reported in the United States last year, the highest number in 10 years. Around 2010, total annual cases were down in the hundreds. Most of the recent cases occurred in outbreaks, including a large one in Arkansas, rather than as a sporadic here-a-case, there-a-case disease. Most of the outbreaks were among people 18 to 22 years old, most of whom had had the requisite two doses of mumps vaccine in childhood. “We are seeing it in a young and highly vaccinated population,” Dr. Routh said. Mumps is transmitted by droplets of saliva or mucus. It can be spread by coughing and sneezing, but also by sharing cups ... close contact. Many of the recent outbreaks occurred in college dorms or among athletic teams. Mumps vaccine is now combined with measles and rubella vaccine in the M.M.R., given at ages 1 and 4. But the immunity wanes over time in some people, and with close contact, there can be sufficient exposure to sufficient quantities of virus to overcome the vaccines’ protection. Dr. Alan Lucerna [also] reported in February 2017 on a case of mumps in a fully immunized adult, in an article titled “Still a pain in the neck after all this time.”

Note: For more along these lines, see concise summaries of deeply revealing news articles on vaccines and health.

The nation’s leading heart experts on Monday issued new guidelines for high blood pressure that mean tens of millions more Americans will meet the criteria for the condition. Under the guidelines ... the number of men under age 45 with a diagnosis of high blood pressure will triple, and the prevalence among women under age 45 will double. The number of adults with high blood pressure, or hypertension, will rise to 103 million from 72 million under the previous standard. The number of people who are new candidates for drug treatment will rise ... by an estimated 4.2 million people. To reach the goals others may have to take more drugs or increase the dosages. The change is due largely to convincing data from a federal study published in 2015. That study, called Sprint, explored whether markedly lower blood pressure in older people - lower than researchers had ever tried to establish - might be both achievable and beneficial. In participants who were assigned to get their systolic pressures below 120, the incidence of heart attacks, heart failure and strokes fell by a third, and the risk of death fell by nearly a quarter. But more intensive drug treatment in so many more patients may increase rates of kidney disease. In the Sprint trial, the incidence of acute kidney injury was twice as high in the group receiving drugs to reduce their systolic pressure to 120. Lifestyle changes like diet and exercise can help many patients lower blood pressure. But many of the newly diagnosed are likely to wind up on drugs.

Note: The effect of this huge change is that billions more dollars will now flow into Big Pharma as millions of consumers are led to believe their blood pressure is dangerously high. Are drugs the best answer? For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption and health.

President Donald Trump on Monday announced he is nominating Alex Azar, a former pharmaceutical company executive and George W. Bush administration official, to succeed Tom Price as the secretary of the Department of Health and Human Services. He previously served as HHS general counsel and deputy secretary for President George W. Bush. Following his time with the administration, he worked for pharmaceutical giant Eli Lilly & Co. [He] became president of Lilly USA in 2012. As part of his role at Lilly USA, Azar was on the board of directors for the Boards of the Biotechnology Industry Organization (BIO), a drug lobbying group. In an October letter, Reps. Raul Grijalva, D-Arizona, Mark Pocan, D-Wisconsin, and Jan Schakowsky, D-Illinois, wrote that under his leadership, Azar's company fought "against federal and state legislation to increase drug pricing transparency." And a lawsuit filed in Massachusetts in early 2017 alleges that the company shot up prices on insulin "in near lock step" with two other pharmaceutical manufacturers. Following Yale Law School, Azar clerked for Supreme Court Justice Antonin Scalia, and later joined the Whitewater independent counsel headed by his "mentor" Ken Starr.

Note: Rather than draining the swamp, Trump continues to deepen the swamp in his administration. Besides this most recent appointment, he has installed Goldman Sachs executives as his Treasury secretary, top economic adviser, deputy national security adviser and chief strategist. Even his top Wall Street regulator is a former attorney for Goldman. For more, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry.

Opposition from France and Italy doomed a European Union vote on Thursday to reauthorize the world’s most popular weedkiller, glyphosate, a decision that came hours after Arkansas regulators moved to ban an alternative weedkiller for much of 2018. The decisions are a double blow to the agrochemical industry and particularly to the chemicals giant Monsanto. The effort to reauthorize the weedkiller failed to receive a majority even though regulators were seeking only a five-year reauthorization instead of the typical 15, amid controversy and disputes about cancer risk that have made glyphosate’s future in Europe uncertain. Its approval in the region expires in mid-December. In Arkansas, regulators voted on Wednesday to ban the use of another major weedkiller, dicamba ... amid widespread reports of crop damage. Dicamba has been around for decades, but new versions have been developed by Monsanto, BASF and DuPont as an alternative to Roundup. Taken together, the decisions reflect an increasing political resistance to pesticides in Europe and parts of the United States, as well as the specific shortcomings of dicamba. Dicamba has damaged more than 3.6 million acres of soybean crops in 25 states. The European Union’s decision followed years of haggling and delay. But glyphosate ... has been plunged into controversy since the International Agency for Research on Cancer, part of the World Health Organization, declared it a probable carcinogen in 2015.

Note: Monsanto was recently banned from the European parliament after shunning important hearings with regulators. This company's use of scientists as industry puppets, its lies to regulators and the public and its massive lobbying campaign have not kept information on the risks and dangers of its products from getting out. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

Intermittent fasting can keep the body ‘young’ at a cellular level. Researchers at Harvard found that temporarily restricting diet keeps the mitochondria – an important part of the cell to health aging – in homeostasis, which in turn helps to improve lifespan. Last year, Newcastle University research confirmed the crucial role of the mitochondria in human cell aging, and therefore, the aging of our bodies. Mitochondria break down carbohydrates and fatty acids, giving energy to the cell. For this reason, they are often referred to as the ‘powerhouses’ of our cells. The Newcastle University researchers found that without their aged mitochondria, cells appeared younger. Mitochondria exist in two states, and when they are alternating appropriately between these two states, they are in homeostasis. The Harvard researchers found that mitochondria stay in homeostasis better when an organism – in their study, a nematode worm – has an intermittently restricted diet. At the same time, being able to swing as they’re supposed to from one state to the other is key to the longevity-enhancing effects of intermittent fasting. The researchers also found that intermittent fasting helped to coordinate the activities of the mitochondria with peroxisomes, other cell parts that have an antioxidant effect and contribute to longevity. This newfound understanding of how fasting works at a cellular level could be a key to discovering therapies that could be beneficial to extending life expectancies and keeping the body younger.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Monsanto is under fire because the company's herbicide, Roundup (active ingredient: glyphosate), is suspected of being carcinogenic. The longstanding dispute about glyphosate has been brought to a head by the release of explosive documents. Monsanto's strategies for whitewashing glyphosate have been revealed in internal e-mails, presentations and memos. Even worse, these "Monsanto Papers" suggest that the company doesn't even seem to know whether Roundup is harmless to people's health. "You cannot say that Roundup is not a carcinogen," Monsanto toxicologist Donna Farmer wrote in one of the emails. "We have not done the necessary testing on the formulation to make that statement." The email ... is one of more than 100 documents that a court in the United States ordered Monsanto to provide as evidence after about 2,000 plaintiffs demanded compensation from Monsanto in class-action suits. They claim that Roundup has caused non-Hodgkin's lymphoma, a form of lymph node cancer. "The Monsanto Papers tell an alarming story of ghostwriting, scientific manipulation and the withholding of information," says Michael Baum, a partner in [a] law firm ... bringing one of the US class actions. Monsanto ... also behaved irresponsibly when it comes to the question of Roundup's absorption into the body. Back in 2002, the company's experts discovered that "between 5 and 10 percent" of the substance penetrated the skin of rats. As a consequence, the author of the email wrote: "We decided thus to STOP the study."

Note: Monsanto was recently banned from the European parliament after shunning important hearings with regulators. This company's use of scientists as industry puppets, its lies to regulators and the public and its massive lobbying campaign have not kept information on the risks and dangers of its products from getting out. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

The latest study to look at the long-term effects of Roundup, a popular weed killer developed by Monsanto in the 1970s, raises questions about the herbicide’s possible contributions to poor health. The study ... tracked people over the age of 50 in southern California from 1993-1996 to 2014-2016, with researchers periodically collecting urine samples. The percentage of people who tested positive for a chemical called glyphosate, which is the active ingredient in the herbicide Roundup, shot up by 500% in that time period. The levels of glyphosate also spiked by 1208% during that time. Exactly what that means for human health isn’t quite clear yet. One trial from the UK, in which rats were fed low levels of glyphosate throughout their lives, found that the chemical contributed to ... a condition in which fat accumulates in the liver and contributes to inflammation and scarring of the tissue. [Researcher Paul] Mills says that the levels of glyphosate documented in the people in his study were 100-fold greater than those in the rats. Mills says the findings should make people more aware of what they are ingesting along with their food. While Roundup was developed to eliminate most weeds from genetically modified crops - and thus reduce the amount of pesticides sprayed on them - recent studies have found that many weeds are now resistant to Roundup. That means growers are using more Roundup, which could only exacerbate potential negative health effects on people who consume those products.

Note: Glyphosate is the most heavily used agricultural chemical in human history. According to a recent UN report, "the assertion promoted by the agrochemical industry that pesticides are necessary to achieve food security is not only inaccurate, but dangerously misleading." For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

In the midst of the worst drug epidemic in American history, the U.S. Drug Enforcement Administration's ability to keep addictive opioids off U.S. streets was derailed - that according to Joe Rannazzisi, one of the most important whistleblowers ever interviewed by 60 Minutes. Rannazzisi ran the DEA's Office of Diversion Control, the division that regulates and investigates the pharmaceutical industry. He says the opioid crisis was allowed to spread - aided by Congress, lobbyists, and a drug distribution industry that shipped, almost unchecked, hundreds of millions of pills to rogue pharmacies and pain clinics providing the rocket fuel for a crisis that, over the last two decades, has claimed 200,000 lives. His greatest ire is reserved for the ... middlemen that ship the pain pills from manufacturers, like Purdue Pharma and Johnson & Johnson to drug stores all over the country. Rannazzisi accuses the distributors of fueling the opioid epidemic. "This is an industry that allowed millions and millions of drugs to go into bad pharmacies and doctors' offices, that distributed them out to people who had no legitimate need for those drugs," [said Rannazzisi]. In 2013, Joe Rannazzisi and his DEA investigators were trying to crack down. Then ... with the help of members of Congress, the drug industry began to quietly pave the way for legislation that essentially would strip the DEA of its ... ability to immediately freeze suspicious shipments of prescription narcotics to keep drugs off U.S. streets.

Note: See also this informative Washington Post article for more information on this sad topic. Lots more available here. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in pharmaceutical industry.

Federal agents arrested the founder of a major drug company in an early-morning raid Thursday on charges stemming from an alleged scheme to get doctors to illegally prescribe a powerful opioid to patients who don't need it. John Kapoor ... is the billionaire founder and former CEO of the pharmaceutical company Insys Therapeutics. He faces charges including racketeering, conspiracy, bribery and fraud. Kapoor is the most significant pharmaceutical executive to be criminally charged in response to the nationwide opioid crisis. Kapoor stepped down as CEO of Insys in January but still serves on its board. The company makes a spray version of fentanyl, a highly addictive opioid intended only for cancer patients. Authorities allege Insys marketed the drug as part of a scheme to get non-cancer doctors to prescribe it. Numerous physicians were allegedly paid bribes by the company to push the painkilling drug. Insys made 18,000 payments to doctors in 2016 that totaled more than $2 million. Headache doctors, back pain specialists and even a psychiatrist ... received thousands of dollars to promote the drug last year. Last December, six other Insys executives were indicted on federal charges in Boston in connection with the alleged scheme to bribe doctors to unnecessarily prescribe the painkilling drug.

Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption and health.

Stephen Ross spends most of his time helping people quit drugs. But early next year, he will begin administering MDMA in his ... medical research lab. MDMA, aka ecstasy, will still be an illegal drug. But it’s emerging as one of the most promising treatments for intractable post-traumatic stress disorder. Rick Doblin ... encountered MDMA for the first time [in 1982]. Two years later, he watched a patient suffering from PTSD undergo MDMA-assisted therapy. “That completely persuaded me of its therapeutic potential,” Doblin says. In 1985, Doblin learned that the DEA was moving to ban the drug ... and founded a nonprofit - the Multidisciplinary Association for Psychedelic Studies - to fight the prohibition. In 2000 [Doblin] met Michael Mithoefer, a therapist specializing in PTSD. Mithoefer had grown frustrated by the available treatments. Mithoefer and his wife and co-therapist, Annie, conducted the first MAPS-funded Phase II trial in 2004, which used MDMA to treat PTSD in victims of rape and childhood sexual abuse. These were patients with chronic cases that had proved resistant to other treatment methods. A second group, made up of veterans, firefighters and police officers, followed. Therapists refer to MDMA as an empathogen - something that enables patients to feel empathy not just for others but also for themselves. Of the 90 people who completed the 12-month follow-up after Phase II, 68% of them “did not meet PTSD criteria,” according to the study results MAPS submitted to the FDA. Of the remaining third, many had some reduction in symptoms.

Note: Read more about how MDMA has been found effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.